(-)-Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers

Planta Med. 2011 Jul;77(10):1013-9. doi: 10.1055/s-0030-1270724. Epub 2011 Feb 15.

Abstract

The proto-oncogene receptor tyrosine kinase c-Met encodes the high-affinity receptor for hepatocyte growth factor (HGF). Dysregulation of the HGF-c-Met pathway plays a significant oncogenic role in many tumors. Overexpression of c-Met is a prognostic indicator for some transitional cell carcinomas. Extra-virgin olive oil (EVOO) provides a variety of minor phenolic compounds with beneficial properties. (-)-Oleocanthal (1) is a naturally occurring minor secoiridoid isolated from EVOO, which showed potent anti-inflammatory activity via its ability to inhibit COX-1 and COX-2. It altered the structure of neurotoxic proteins believed to contribute to the debilitating effects of Alzheimer's disease. Computer-Assisted Molecular Design (CAMD) identified 1 as a potential virtual c-Met inhibitor hit. Oleocanthal inhibited the proliferation, migration, and invasion of the epithelial human breast and prostate cancer cell lines MCF7, MDA-MB-231, and PC-3, respectively, with an IC (50) range of 10-20 µM, and demonstrated anti-angiogenic activity via downregulating the expression of the microvessel density marker CD31 in endothelial colony forming cells with an IC (50) of 4.4 µM. It inhibited the phosphorylation of c-Met kinase IN VITRO in the Z'-LYTE™ assay, with an IC (50) value of 4.8 µM. (-)-Oleocanthal and EVOO can have potential therapeutic use for the control of c-Met-dependent malignancies.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Aldehydes / metabolism
  • Aldehydes / pharmacology*
  • Angiogenesis Inhibitors / pharmacology
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Binding Sites
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Cyclopentane Monoterpenes
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Female
  • Humans
  • Inhibitory Concentration 50
  • Male
  • Models, Molecular
  • Neoplasm Invasiveness / pathology
  • Neovascularization, Pathologic / drug therapy
  • Olive Oil
  • Phenols / metabolism
  • Phenols / pharmacology*
  • Plant Oils / chemistry
  • Platelet Endothelial Cell Adhesion Molecule-1 / drug effects
  • Platelet Endothelial Cell Adhesion Molecule-1 / metabolism
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology
  • Protein Kinases / drug effects
  • Protein Kinases / metabolism
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-met / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-met / metabolism

Substances

  • Aldehydes
  • Angiogenesis Inhibitors
  • Antineoplastic Agents, Phytogenic
  • Cyclopentane Monoterpenes
  • MAS1 protein, human
  • Olive Oil
  • Phenols
  • Plant Oils
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Proto-Oncogene Mas
  • Adenosine Triphosphate
  • oleocanthal
  • Protein Kinases
  • Proto-Oncogene Proteins c-met